A prior authorization is a requirement from your health insurance plan that your doctor get approval before a specific medication will be covered. If your prescription needs prior authorization, your pharmacy will let you know it can’t be filled under your insurance until your doctor’s office submits a request and the insurer signs off. Without that approval, you’ll either pay full price out of pocket or wait until the process is complete.
This is one of the most common roadblocks people hit at the pharmacy counter, and it can feel confusing when it happens. Here’s how it actually works, why insurers require it, and what you can do if your request is denied.
How the Process Works
Your doctor’s office handles the prior authorization, not you. When your pharmacy flags that a medication requires approval, your prescriber submits a request to your insurance company explaining why the drug is medically necessary. That request typically includes your diagnosis, what other treatments you’ve already tried, and why this particular medication is the right choice. If you’ve had side effects from cheaper alternatives or those drugs simply didn’t work, your doctor will document that as well.
The insurer reviews the request and sends a written decision to both you and your doctor. For non-urgent requests, this can take up to 30 days, though a federal rule taking effect in 2026 will require many insurers to respond within seven days for standard requests. If your doctor considers the situation urgent, they can file an expedited request, which currently gets a response within 72 hours. Some states already mandate faster turnaround: Washington, D.C., New Jersey, and Vermont all require a response within 24 hours for urgent cases.
Why Insurers Require It
Prior authorization exists primarily as a cost control tool. Insurers use it to steer prescribing toward less expensive alternatives when those alternatives are equally effective for most patients. If a brand-name drug costs ten times more than a generic that treats the same condition, the insurer wants documentation that the cheaper option isn’t appropriate for you before it agrees to pay for the expensive one.
Insurers also frame prior authorization as a safety check, ensuring that high-risk or complex medications are being prescribed appropriately. In practice, though, the process is broadly applied. A 2021 analysis published in The BMJ found that 74% of physician-administered medications in Medicare Advantage would have required prior authorization from at least one insurer. Across all services, the median Medicare Advantage plan required prior authorization for about 22% of utilization, but some plans applied it to as much as 41%.
Which Medications Typically Need It
Not every prescription triggers a prior authorization. The drugs most likely to require one fall into a few categories:
- Brand-name drugs with generic alternatives. If a cheaper equivalent exists, your insurer will often require you to try it first.
- Specialty medications. These are high-cost drugs used for complex conditions like cancer, rheumatoid arthritis, or multiple sclerosis. They’re almost always subject to prior authorization.
- Non-preferred drugs on your plan’s formulary. Every insurance plan has a tiered list of covered medications. Drugs on lower-preference tiers are more likely to need approval.
- Medications with safety concerns. Certain drugs that carry risks of dependence, serious side effects, or dangerous interactions may require extra documentation.
Your plan’s formulary, usually available on your insurer’s website, will indicate which drugs require prior authorization. Checking before your doctor writes the prescription can save time.
Step Therapy: A Related Requirement
You may also encounter something called step therapy, sometimes known as “fail first.” This is a specific type of prior authorization where your insurer requires you to try one or more preferred medications before it will cover the drug your doctor originally prescribed. The logic is that you start with the most cost-effective option and only move to alternatives if that first step doesn’t work or causes problems.
If your doctor believes step therapy is inappropriate for your situation, perhaps because you’ve already tried the preferred drug in the past or it would be unsafe given your other conditions, they can request an exception. The key is providing documentation that supports skipping the required steps.
What Happens When a Request Is Denied
Denials are common, and the reasons aren’t always clear. The American Medical Association has pushed back on insurers who issue denials without detailed explanations, noting that patients and doctors are sometimes simply told a medication “has not been granted prior authorization” with no further justification. Under AMA-backed policy, denial letters should include the specific reason for the denial, what additional documentation might lead to approval, and alternative medications the plan would cover.
If your request is denied, you have the right to appeal. The process varies by insurance type, but for Medicare Part D plans, it follows a structured path:
- First-level appeal: You file with your plan within 60 days of the denial. The plan has 7 days to issue a standard decision, or 72 hours for expedited cases.
- Second-level appeal: If the plan upholds its denial, an independent review entity examines the case on the same timeline.
- Further appeals: Additional levels include hearings through the Office of Medicare Hearings and Appeals and, ultimately, federal court, though most cases resolve well before that point.
Private insurance plans have their own appeals processes, which are outlined in your plan documents. The steps are generally similar: an internal appeal to the insurer, followed by an external review by an independent party.
How to Strengthen Your Case
Whether you’re going through the initial request or an appeal, the most important thing you can do is work closely with your prescribing doctor. Your doctor should write a letter of support explaining why you need the specific medication and, if applicable, why alternatives are ineffective or unsafe for you. If you’ve previously tried and failed on the insurer’s preferred drugs, that history needs to be clearly documented.
For quantity limit denials, where the insurer approves the drug but at a lower dose or fewer pills than prescribed, your doctor should explain and document why the higher quantity is medically necessary. For drugs being prescribed off-label (for a use not specifically approved by the FDA), including supporting evidence from recognized medical references significantly improves the chances of approval.
Keep copies of all correspondence. If you’re waiting on a decision and running low on medication, ask your doctor about options like short-term samples, a temporary supply at the pharmacy, or patient assistance programs. Organizations like the PAN Foundation provide financial assistance to help people start or continue treatment while navigating insurance barriers, having helped more than 1.3 million people since 2004.
Regulatory Changes Ahead
The prior authorization landscape is shifting. In 2024, the Centers for Medicare and Medicaid Services finalized a rule that will require many payers to send prior authorization decisions within 72 hours for urgent requests and within seven days for non-urgent ones, starting in January 2026. By January 2027, insurers will need to support electronic prior authorization through standardized technology, which should reduce the back-and-forth paperwork that currently slows the process.
At the state level, more legislatures are passing laws that cap response times and require insurers to provide detailed denial reasons. The AMA is pushing for a national standard of 48-hour turnaround for non-urgent requests and 24 hours for urgent ones. These changes won’t eliminate prior authorization, but they should make the process faster and more transparent for both patients and doctors.